Brief: Immuneoncia Therapeutics To Conduct Capital Increase Of 120 Billion Won For Operational Funds
ImmuneOncia Therapeutics Inc 424870.KQ: IMMUNEONCIA THERAPEUTICS: TO CONDUCT CAPITAL INCREASE OF 120 BILLION WON FOR OPERATIONAL FUNDS Source text: [ID:] Further company coverage: 424870.KQ